CargoAdmin, Bureaucrats, Moderators (CommentStreams), fileuploaders, Interface administrators, newuser, Push subscription managers, Suppressors, Administrators
5,223
edits
Cardiovascular and Renal Drugs Advisory Committee: Difference between revisions
Cardiovascular and Renal Drugs Advisory Committee (view source)
Revision as of 09:34, 31 March 2025
, 31 Marchno edit summary
No edit summary Tag: Manual revert |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Organization | {{Organization | ||
|OrganizationName=Cardiovascular and Renal Drugs Advisory Committee | |OrganizationName=Cardiovascular and Renal Drugs Advisory Committee | ||
|OrganizationType=Boards, Commissions, and Committees | |OrganizationType=Boards, Commissions, and Committees | ||
|Mission= | |Mission=Cardiovascular and Renal Drugs Advisory Committee advises FDA on safety and efficacy of drugs for heart and kidney disorders for public health | ||
|ParentOrganization=Food and Drug Administration | |||
|TopOrganization=Department of Health and Human Services | |||
|OrganizationExecutive=Designated Federal Officer | |OrganizationExecutive=Designated Federal Officer | ||
|Services=Review and evaluation of drug products; advisory consultations; safety assessments | |Services=Review and evaluation of drug products; advisory consultations; safety assessments | ||
|Regulations=Clean Air Act; Clean Water Act; Comprehensive Environmental Response, Compensation, and Liability Act; Resource Conservation and Recovery Act; Safe Drinking Water Act (relevant to drug safety and environmental impact) | |Regulations=Clean Air Act; Clean Water Act; Comprehensive Environmental Response, Compensation, and Liability Act; Resource Conservation and Recovery Act; Safe Drinking Water Act (relevant to drug safety and environmental impact) | ||
|HeadquartersLocation=38. | |HeadquartersLocation=38.99583, -77.02639 | ||
|HeadquartersAddress=10903 New Hampshire Ave, Silver Spring, MD 20993 | |HeadquartersAddress=10903 New Hampshire Ave, Silver Spring, MD 20993 | ||
|Website=https://www.fda.gov/advisory-committees/cardiovascular-and-renal-drugs-advisory-committee | |||
}} | }} | ||
'''Cardiovascular and Renal Drugs Advisory Committee (CRDAC)''' is part of the U.S. Food and Drug Administration (FDA) and advises on matters related to the development, safety, and effectiveness of drugs intended for the treatment of cardiovascular and renal diseases. The committee is based in Silver Spring, Maryland. | '''Cardiovascular and Renal Drugs Advisory Committee (CRDAC)''' is part of the U.S. Food and Drug Administration (FDA) and advises on matters related to the development, safety, and effectiveness of drugs intended for the treatment of cardiovascular and renal diseases. The committee is based in Silver Spring, Maryland. | ||